Overuse of Surveillance in Bladder Cancer, Despite Guidelines
[ad_1] Clinicians are not following guidelines that recommend a de-escalation in surveillance for patients with low-risk non–muscle-invasive bladder cancer (NMIBC), a new study concludes. These cancers are associated with low rates of recurrence, progression, and bladder cancer-specific death, and so current clinical practice guidelines recommend against frequent monitoring and testing. However, the study authors…